Analytics Legal analytics

24
March
2014

Commercial policies of pharmaceutical companies and medical device manufacturers: new lessons for market players

Federal Antimonopoly Service (FAS) and Russian court practice in addressing unreasonable refusals to enter into a supply agreement continues to develop. Several new cases considered by the FAS and the courts at the end of 2013/beginning of 2014 have enabled the identification of new trends in legal implementation policies.
We would like to offer you an analytical survey of VEGAS LEX on COMMERCIAL POLICIES OF PHARMACEUTICALS COMPANIES AND MEDICAL DEVICE: NEW LESSONS FOR MARKET PLAYERS.
In our latest issue:

  • Who is at risk?
  • How is market share determined?
  • What exactly may reveal a restraint on competition?
  • What to do next?
*The analytical survey of VEGAS LEX is an information periodical of law firm VEGAS LEX the main purpose of which is to inform the readers about the recent changers in legislation, court practice and other significant legal issues of business operation. 

VEGAS LEX_Коммерческие политики производителей лекарственных препаратов.Новые уроки для бинеса

Download file
File added 12.08.2015
Presentation .pdf (398 Кб)

VEGAS LEX_Legal Alert_(eng)_4_03_2014

Download file
File added 22.09.2015
Presentation .pdf (432 Кб)

Apply to participate

Apply to participate

Оценка:

Download file

Фамилия Имя Отчество*
Компания*
Должность*
E-mail*
By continuing to use this site, you consent to the VEGAS-LEX Law Firm, Moscow, to the processing of cookies and relevant user data (IP address, location information, OS type and version, browser type and version, device type and screen resolution, source of access to the site, operating system and browser language, behavior on the site) for the purpose of functioning of the site, conducting statistical research and web analytics, including using third-party services. If you do not want your data to be processed, change the appropriate settings of your browser or leave the site.
More info Accept